It has been reported that FAM83A promotes the progression of lung adenocarcinoma by regulating the Wnt and Hippo [8] and ERK and PI3K/Akt/mTOR pathways [13], making it a promising therapeutic target. The gene discussed is SACK1A; the disease is lung adenocarcinoma.